This award is intended for junior faculty who meet the criteria for Early Stage Investigator, as defined by the National Institutes of Health (NIH). Note, those who have received substantial NIH research awards, such as being a PI on an R01, P01, or U01, are not Early Stage Investigators, according to NIH criteria. A list of NIH grants that a PI can hold and still be considered an Early Stage Investigator.
In addition, applicants must meet the following requirements:
- Hold an MD, PhD, or equivalent degree at the time of award and be associated with a research institution in the United States
For clinical science applicants: you should be no more than 7 years from the completion of specialty training at the time of application (e.g. medical oncology, radiation oncology, surgical oncology, pediatric oncology, or equivalent)
For basic science applicants: you should have received your initial faculty appointment no more than 7 years at the time of application.
- Applicants who hold positions that are more senior than Assistant Professor level (or equivalent) at the time of application are not eligible
- Have a research mentor with extensive experience in the field of hematology/oncology (co-mentorship is permissible)
- Be able to devote approximately 30% or more of professional time to research for the next 2 years (versus administrative, patient care, or teaching responsibilities)
- Be able to complete the proposed research within the 2-year award period, providing evidence (manuscript, presentation, or abstracts) resulting from the research
Exceptions to the above can apply, for example, having taken time out for parental leave or family bereavement.
The Research Scholars Program is actively working towards reducing potential barriers to entry and success for applicants from population groups who are typically underrepresented in research. Award selections are made without discrimination based on race, ethnicity, religion, national origin, gender, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression.
We are committed to supporting researchers and research projects addressing unmet patient needs and health inequities in order to build a more inclusive research landscape.
An applicant must be a citizen or permanent resident of the United States or subject to the qualifications noted below hold a temporary non-immigrant visa/work permit .This visa must be valid and must allow the applicant to undertake the research over the two-year award period from the United States. This non-immigrant visa/work permit must be valid for the two-year award period or applicant must be able to establish that he or she is eligible for an extension, renewal or other status that will enable the applicant to perform the research in the applicable jurisdiction for the entirety of the two year award period.
- GILEAD and the GILEAD logo are registered
- trademarks of Gilead Sciences, Inc., or one of its related companies. Kite
- and the Kite Logo are registered trademarks of Kite, a Gilead company.
- © 2022 Gilead Sciences, Inc. All rights reserved.